home

US Market news

headline news | recent news | latest news | market news | recent topics | stock topics

Global news - chevrons indicate local prediction, arrows show global predictions, circles show importance

TTWO US
Take-Two Buys Gearbox And Its New Borderlands Game From Embracer
Its just been announced that Take-Two, which owns GTA developer Rockstar, will purchase Gearbox for $460 million. - forbes
23m ago
link
RSLS US
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Patent Significantly Strengthens Intellectual Property Portfolio Patent Significantly Strengthens Intellectual Property Portfolio - globenewswire
23m ago
link
NBIX US
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults
SAN DIEGO, March 28, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced the initiation of its Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1065890 in healthy adult... - prnewswire:443
24m ago
link
BLIN US
Bridgeline Releases Zeus Update with Concept and Image Search
WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, announced that Smart Search by HawkSearch, featuring AI powered concept and image search with Generative AI (GenAI) capabilities, is now available to the general public. - globenewswire
24m ago
link
TENX US
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
CHAPEL HILL, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced full year 2023 financial results, and provided clinical development and business updates. - globenewswire
24m ago
link
FRF US
CISO Global Enters into Exclusive Agreement With Fortegra
Global cybersecurity provider and multinational specialty insurer join forces to uniquely provide cyber warranty protection for CISO Global clients - globenewswire
24m ago
link
CC US
Why Chemical Company Chemours Shares Are Plunging Premarket Today
The Chemours Company  (NYSE: CC ) shares are trading lower after the company disclosed the completion and result of an internal review by the  Audit Committee of the Board of Directors. The Audit Committee determined the delayed payments of up to around $100 million until the first quarter of 2024 to certain vendors that were originally due to be paid in the fourth quarter of 2023. The Committee also stated the collection of up to about $260 million of receivables originally not due to be received until the first quarter of 2024 were accelerated into the fourth quarter of 2023.  Overall, the Audit Committee determined that there was a lack of transparency with the Board of Directors by three former members of senior management.  The company also revealed material weaknesses in financial reporting. The material weaknesses did not result in ... Full story available on Benzinga.com - benzinga
38m ago
link
AAPL US
New iPhone Password Attack Warning Issued To Apple Users
Apple iPhone users are being targeted in a new attack targeting the password reset feature. Here's what you need to know. - forbes
38m ago
link
AAPL US
Surprise New iPhone Security Warning For iMessage Users In 100 Countries
If you are an iPhone user and think that iMessage can save you from malicious actors, think again. This security threat has risen from the dead to target you. - forbes
39m ago
link
EBS US
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
As the first-ever U.S. Food and Drug Administration(FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands of NARCAN ® Nasal Spray cartons are available in over 32,000 retail locations in the U.S., and Emergent is working to increase reach into workplaces, businesses and other locations Approximately 22 million doses of NARCAN ® Nasal Spray were distributed in the U.S. and Canada in 2023, and Emergent is committed to meeting any increase in demand driven by the evolving and worsening epidemic The recently announced White House Challenge to Save Lives from Overdose' is a nationwide call-to-action that includes increasing access to life-saving opioid overdose reversal medications, a program with direct alignment to Emergent's strategy and efforts since the launch of NARCAN ® N - benzinga
39m ago
link
NEWR US
Avoiding Security Theatre With Tigera, New Relic And JFrog
Vendors including Tigera/Calico, New Relic and JFrog are providing better security tools that take customer context into account. - forbes
39m ago
link
MTEM US
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies, to create novel therapies with potent and differentiated mechanisms of action for cancer, announced today it has entered into a definitive amended and restated securities purchase agreement with certain healthcare investors that will provide $9.5 million in gross proceeds to MTEM through the closing of the second tranche of its previously announced July 2023 private placement and purchase agreement on amended terms. The financing is being led by existing investor BVF Partners L.P. and includes existing investors BB Biotech AG and Sant, and other leading institutional investors. - globenewswire
43m ago
link
ULTA US
Le Monde Gourmand Announces Retail Partnership with Ulta Beauty
NEW YORK, March 28, 2024 /PRNewswire/ -- Le Monde Gourmand, a leading fragrance and self-care brand under the parent company Tru Fragrance & Beauty, proudly announces its latest retail partnership with Ulta Beauty, the nation's largest beauty retailer. Beginning March 24, 2024,... - prnewswire:443
44m ago
link
AGRX US
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% - globenewswire
49m ago
link
MCHP US
Microchip Technology Expands Its Serial SRAM Portfolio to Larger Densities and Increased Speeds
Microchips 2 Mb and 4 Mb serial SRAM devices are intended to replace expensive parallel SRAM with an easy and cost-effective alternative. - globenewswire
51m ago
link
TSLA US
Tesla has had a nightmare first quarter amid weak China demand, says this longtime bull
Wedbushs Dan Ives trims his stock-price target to $300 from $315 after a perfect storm of issues. - marketwatch
52m ago
link
VNO US
Where Vornado Realty Stands With Analysts
Across the recent three months, 4 analysts have shared their insights on Vornado Realty (NYSE: VNO ), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 2 1 1 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 0 1 1 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Vornado Realty, presenting an average target of $24.75, a high estimate of $26.00, and a low estimate of $21.00. Highlighting a 6.6% decrease, the current average has fallen from the previous average price target of $26.50. Understanding Analyst Ratings: A Comprehensive Breakdown In examining recent anal - benzinga
52m ago
link
CARA US
Demystifying Cara Therapeutics: Insights From 4 Analyst Reviews
Throughout the last three months, 4 analysts have evaluated Cara Therapeutics (NASDAQ: CARA ), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 Analysts have set 12-month price targets for Cara Therapeutics, revealing an average target of $6.25, a high estimate of $10.00, and a low estimate of $5.00. This current average represents a 26.47% decrease from the previous average price target of $8.50. Breaking Down Analyst Ratings: A Detailed Examination The perception of Cara Therapeutics by financial experts is analyzed - benzinga
53m ago
link
DIS US
A Baltimore bridge collapse timeline; Disney and DeSantis settle legal battle
Two bodies were recovered from the Baltimore bridge collapse and investigators released a timeline of events. The Walt Disney Company and Gov. Ron DeSantis have settled their lawsuits. - npr org
53m ago
link
ARQT US
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
WESTLAKE VILLAGE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT ), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the 23 rd Annual Needham Virtual Healthcare Conference, taking place April 8-11, 2024. Details for the company's participation are as follows: Fireside Chat Date: Thursday, April 11, 2024 Fireside Chat Time : 2:15 pm EDT The webcast for this conference may be accessed at the ' Events ' section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT ) is a commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs ... Full story available on Benzinga - benzinga
54m ago
link
COCP US
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
BOTHELL, Wash., March 28, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the 12 months ended December 31, 2023, and provides updates on its antiviral product pipeline, upcoming milestones and business activities. - globenewswire
54m ago
link
CB US
Chubb Limited to Hold its First Quarter Earnings Conference Call on Wednesday, April 24, 2024
ZURICH, March 28, 2024 /PRNewswire/ -- Chubb Limited (NYSE: CB) will hold its first quarter earnings conference call on Wednesday, April 24, 2024, at 8:30 a.m. Eastern. The company expects to issue its first quarter earnings release and financial supplement after the market closes on... - prnewswire:443
1h ago
link
FOXF US
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Fox Factory Holding Corp. Investors of Upcoming Deadline
- - globenewswire
1h ago
link
INMD US
DEADLINE ALERT: Bernstein Liebhard LLP Reminds InMode Ltd. Investors of Upcoming Deadline
- - globenewswire
1h ago
link
IRBT US
DEADLINE ALERT: Bernstein Liebhard LLP Reminds iRobot Corporation Investors of Upcoming Deadline
- - globenewswire
1h ago
link
NVDA US
Investment Bank Piper Sandler Removes Nvidia From Model Portfolio, Anticipating S&P 500 Correction: 'Cool The Engines'
Investment bank Piper Sandler is forecasting a correction in the S&P 500 and has consequently removed Nvidia Corp. (NASDAQ: NVDA ) from its model portfolio, What Happened : Despite a robust first quarter for stocks, Piper Sandler’s Chief Market Technician, Craig Johnson , foresees a 5% to 10% correction in the S&P 500 in the near term, CNBC reported on Thursday. Johnson points to inflated valuations and decelerating momentum as the primary causes for the predicted downturn. “As investors show complacency within the current uptrend and exhibit a Fear-Of-Missing-Out (FOMO), we believe now is the time to be more vigilant and Cool The Engines,'” Johnson stated on Wednesday. See Also: Jim Cramer Jokes About The ‘Bright Side’ Of GameStop Skipping Earnings Call After Stock Falls Nearly 17%: ‘I Don’t Have To Listen To…’ Notably, Johnson has removed Nvidia, a significant contributor in the AI sector and a k - benzinga
1h ago
link
CWH US
Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024
XIAMEN, China, March 28, 2024 /PRNewswire/ -- Allprostar(Xiamen) Industrial Co.,Ltd has over 16 years of experience outdoor product development and manufacturing and dedicates to providing high and innovative solutions for enthusiasts. Under our flagship brand COMCOCO and CONCONA for... - prnewswire:443
1h ago
link
GOGO US
Gogo Testing for Global Broadband Antenna Achieves Major Milestone
Gogo Galileo Remains on Track for Commercial Launch Later This Year BROOMFIELD, Colo., March 28, 2024 /PRNewswire/ -- Gogo Business Aviation (NASDAQ: GOGO) today announced it has achieved another important milestone with its Gogo Galileo global broadband service completing end-to-end... - prnewswire:443
1h ago
link
MIST US
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
MONTREAL and CHARLOTTE, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc.(NASDAQ: MIST ), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for etripamil, the Company's lead investigational product for the management of paroxysmal supraventricular tachycardia (PSVT). 'We appreciate FDA's guidance through the resubmission process. We believe we have addressed all the issues raised in the Refusal to File letter and look forward to working with the Agency as it reviews our application,' said Joseph Oliveto, President, and Chief Executive Officer of Milestone Pharmaceuticals. 'If approved, we believe that etripamil nasal spray will be a valuable treatment option for patients suffering from PSVT.' The NDA for etripamil was resubmitted based on guidance from the FDA o - benzinga
1h ago
link
PYRNF US
PyroGenesis Schedules 2023 Fiscal Year Financial Results and Business Update Conference Call
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. ( http://pyrogenesis.com ) (TSX: PYR ) (OTCQX: PYRGF ) (FRA: 8PY), a high-tech company (the 'Company' or 'PyroGenesis') that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, today announces that it plans to host a conference call at 10:00 AM Eastern Time on Tuesday April 2, 2024, to discuss the Company's financial results for the fiscal year ended December 31, 2023, as well as the Company's progress and other developments. To access the conference call, please pre-register using this link . Registrants will receive confirmation with dial-in details. A live webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/2xsm32f7 or on the Investor Relations section of the Company's web site by clicking here . About PyroGene - benzinga
1h ago
link
NVDA US
Nvidia's Blackwell Chip Is Here. How Will the Red-Hot 'Magnificent Seven' Company's New GPU Affect the Artificial Intelligence (AI) Landscape?
Nvidia is poised to release an incredibly powerful new AI processor later this year, and it could change the world. - fool
1h ago
link
MDR US
McDermott Reaches Mechanical Completion on Pioneering Biosurfactants Project
HOUSTON, March 28, 2024 /PRNewswire/ -- McDermott today announced mechanical completion of a pioneering industrial-scale biosurfactant plant for Evonik. Less than two years from contract award, Evonik has achieved initial production of Rhamnolipids, a bacterial surfactant with the... - prnewswire:443
1h ago
link
CASI US
CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year... - prnewswire:443
1h ago
link
GRTX US
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Company continues to evaluate strategic options to maximize shareholder value Company continues to evaluate strategic options to maximize shareholder value - globenewswire
1h ago
link
GILD US
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
-- Gilead Granted Exclusive License to Xilios Tumor-Activated IL-12 Program, Including XTX301, a Clinical-Stage IL-12 Molecule with Potential to Treat a Broad Range of Cancers -- FOSTER CITY, Calif. and WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilios Phase 1 tumor-activated IL-12 program, XTX301. - globenewswire
1h ago
link
DTST US
Data Storage Corporation Reports Record Revenue of $25 Million andAchieves Profitability for the 2023 Fiscal Year
MELVILLE, N.Y., March 28, 2024 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (DSC and the Company), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security, and IT services, today provided a business update and reported financial results for the year ended December 31, 2023. - globenewswire
1h ago
link
TLRY US
Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024
Tilray Brands will release financial results for its third quarter ended February 29, 2024, on April 9, 2024. - globenewswire
1h ago
link
SLB US
Schlumberger Expands Carbon Capture Reach Through Aker ACC Deal: Details
Schlumberger N.V.  (NYSE: SLB ) said it has entered into a deal with Aker Carbon Capture (ACC) to merge its carbon capture division,  aiming to advance large-scale industrial decarbonization. Following the transaction, Schlumberger will own 80% of the combined business, and ACC will own 20%. Schlumberger will pay NOK 4.12 billion ($380.86 million) to acquire a majority stake at ACC. Schlumberger said in a press release that it may also make additional payments of up to NOK 1.36 billion over the next three years based on the performance of the business. The combination will leverage ACC’s commercial carbon capture product offering and SLB’s new ... Full story available on Benzinga.com - benzinga
2h ago
link
SLGL US
Sol-gel coatings market size to grow at a CAGR of 11.69% by 2027, Technavio
NEW YORK, March 28, 2024 /PRNewswire/ -- The sol-gel coatings market size is set to unlock a staggering growth potential in the coming years. With an anticipated surge of USD 3,605.23 million and a remarkable Compound Annual Growth Rate (CAGR) of 11.69% projected between 2022 and 2027,... - prnewswire:443
2h ago
link
NVDA US
Cathie Wood Thinks Nvidia Could End Up Like Cisco After the Dot-Com Crash. Here's the 'Magnificent Seven' Stock That I'm More Worried About.
Wood is sounding the alarm on Nvidia following its meteoric rise. - fool
2h ago
link
ICLK US
iClick Appoints Ms. Josephine Ngai as Chief Financial Officer
HONG KONG, March 28, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ('iClick' or the 'Company') (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the... - prnewswire:443
2h ago
link
LITB US
LightInTheBox Files 2023 Annual Report on Form 20-F
SINGAPORE, March 28, 2024 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ('LightInTheBox' or the 'Company'), an apparel e-commerce retailer that ships products to consumers worldwide, today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended... - prnewswire:443
2h ago
link
VIAV US
VIAVI Demonstrates Leadership in RAN Intelligence Test and Training at 2024 RIC Forum
CHANDLER, Ariz., March 28, 2024 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building... - prnewswire:443
2h ago
link
DRIO US
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased. 2023 B2B2C, employers and health plans recurring revenues increased 39% year over year as the core... - prnewswire:443
2h ago
link
MSM US
MSC INDUSTRIAL SUPPLY CO. REPORTS FISCAL 2024 SECOND QUARTER RESULTS
FISCAL 2024 Q2 HIGHLIGHTS Net sales of $935.3 million decreased 2.7% YoY, 290 basis points below the Industrial Production (IP) Index Operating income of $91.2 million, or $97.8 million adjusted to exclude restructuring and other costs as well as acquisition-related costs1 Operating... - prnewswire:443
2h ago
link
ALV US
Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
STOCKHOLM, March 28, 2024 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of March 28, 2024, the total number of issued shares of common stock is 86,126,221 of which 81,373,679 shares are outstanding.... - prnewswire:443
2h ago
link
TSLA US
Teslas Pivot to China Saved Musk. It Also Binds Him to Beijing.
Tesla and China built a symbiotic relationship, with credits, workers and parts that made Mr. Musk ultrarich. Now, his reliance on the country may give Beijing leverage. - nytimes
2h ago
link
NVDA US
Intel Is at the Center of an Industrywide Push to End Nvidia's AI Dominance
Nvidia's software locks in customers and stimies competition. Intel, Google, Qualcomm, and others are pushing an open alternative. - fool
2h ago
link
AON US
American Oncology Network, Inc. (AON) AnnouncesFourth Quarter and Full Year 2023 Financial Results
FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- March 28, 2024 American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three- and twelve-month periods ended December 31, 2023. - globenewswire
2h ago
link
CVX US
Chevron owns this city's news site. Many stories aren't told
Chevron operates a major refinery in Richmond, Calif. It also owns the city's dominant news site, putting its own spin on events, and runs similar sites in Texas and Ecuador. - npr org
2h ago
link